Heike E Daldrup-Link

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi request reprint Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model
    H E Daldrup-Link
    Department of Radiology, Technical University of Munich, Germany
    Eur Radiol 11:1276-84. 2001
  2. ncbi request reprint [Experimental studies of the value of SPIO for MRI of bone marrow before and after whole body irradiation]
    H E Daldrup-Link
    Institut fur Klinische Radiologie, Westfälischen Wilhelms Universität Münster
    Rofo 173:547-53. 2001
  3. ncbi request reprint Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany
    Eur Radiol 12:1557-66. 2002
  4. ncbi request reprint Macromolecular contrast agents for MR mammography: current status
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Ismaninger Strasse 22, 81675 Munich, Germany
    Eur Radiol 13:354-65. 2003
  5. ncbi request reprint Targeting of hematopoietic progenitor cells with MR contrast agents
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Ismaninger Str 22, 81675 Munich, Germany
    Radiology 228:760-7. 2003
  6. ncbi request reprint Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Insmaningerstr 22, 81675 Munich, Germany
    Acad Radiol 10:1237-46. 2003
  7. ncbi request reprint Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Munich, Germany
    Radiology 234:197-205. 2005
  8. ncbi request reprint Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas
    Stephan Metz
    Department of Diagnostic Radiology, Technische Universitaet Muenchen, Ismaninger Str 22, 81675, Munich, Germany
    Eur Radiol 16:598-607. 2006
  9. ncbi request reprint Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Germany
    Acad Radiol 9:S343-7. 2002
  10. ncbi request reprint Highly efficient paramagnetic labelling of embryonic and neuronal stem cells
    Martina Rudelius
    Division of Neuropathology, Institute of Pathology, Technical University, Ismaningerstrasse 22, 81675, Munich, Germany
    Eur J Nucl Med Mol Imaging 30:1038-44. 2003

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model
    H E Daldrup-Link
    Department of Radiology, Technical University of Munich, Germany
    Eur Radiol 11:1276-84. 2001
    ..CMD-A2-Gd-DOTA is a new macromolecular contrast agent with blood-pool effect, significant signal enhancement of abdominal organs and pelvic bone marrow, partial storage in the liver and baseline tissue signal intensities by 10 days p.i...
  2. ncbi request reprint [Experimental studies of the value of SPIO for MRI of bone marrow before and after whole body irradiation]
    H E Daldrup-Link
    Institut fur Klinische Radiologie, Westfälischen Wilhelms Universität Münster
    Rofo 173:547-53. 2001
    ....
  3. ncbi request reprint Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany
    Eur Radiol 12:1557-66. 2002
    ....
  4. ncbi request reprint Macromolecular contrast agents for MR mammography: current status
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Ismaninger Strasse 22, 81675 Munich, Germany
    Eur Radiol 13:354-65. 2003
    ..Potential mammographic applications and limitations of various MMCM, defined by either experimental animal testing or clinical testing in patients, are reviewed in this article...
  5. ncbi request reprint Targeting of hematopoietic progenitor cells with MR contrast agents
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Ismaninger Str 22, 81675 Munich, Germany
    Radiology 228:760-7. 2003
    ..To label human hematopoietic progenitor cells with various magnetic resonance (MR) imaging contrast agents and to obtain 1.5-T MR images of them...
  6. ncbi request reprint Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Insmaningerstr 22, 81675 Munich, Germany
    Acad Radiol 10:1237-46. 2003
    ..To compare the diagnostic performance of the blood pool agent feruglose and the standard extracellular contrast agent gadopentetate in their abilities to differentiate benign and malignant breast tumors...
  7. ncbi request reprint Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Munich, Germany
    Radiology 234:197-205. 2005
    ..To evaluate the use of clinical 1.5-T magnetic resonance (MR) imaging equipment to depict the in vivo distribution of iron oxide-labeled human hematopoietic progenitor cells in athymic mice...
  8. ncbi request reprint Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas
    Stephan Metz
    Department of Diagnostic Radiology, Technische Universitaet Muenchen, Ismaninger Str 22, 81675, Munich, Germany
    Eur Radiol 16:598-607. 2006
    ..Ferumoxtran-10 improved the detection of focal bone marrow lesions significantly (P<0.05)...
  9. ncbi request reprint Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Germany
    Acad Radiol 9:S343-7. 2002
  10. ncbi request reprint Highly efficient paramagnetic labelling of embryonic and neuronal stem cells
    Martina Rudelius
    Division of Neuropathology, Institute of Pathology, Technical University, Ismaningerstrasse 22, 81675, Munich, Germany
    Eur J Nucl Med Mol Imaging 30:1038-44. 2003
    ....
  11. ncbi request reprint Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial
    Heike E Daldrup-Link
    Dept of Radiology, Univ Hosp, Technical Univ of Munich, Ismaningerstr 22, 81675 Munich, Germany
    Radiology 229:885-92. 2003
    ..To investigate use of the macromolecular contrast agent feruglose for differentiating and grading of human benign and malignant breast tumors on the basis of their microvascular characteristics...
  12. ncbi request reprint Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol
    Gerhard H Simon
    Department of Radiology, UCSF Medical Center, University of California, San Francisco, 94143, USA
    Invest Radiol 41:45-51. 2006
    ..We sought to compare the ability of 3 ultrasmall superparamagnetic iron oxides (USPIOs) to detect and characterize antigen-induced arthritis with MR imaging...
  13. ncbi request reprint T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning
    Gerhard H Simon
    Department of Radiology, UCSF Medical Center, University of California San Francisco, San Francisco, California 94143, USA
    Eur Radiol 16:738-45. 2006
    ..5T. In conclusion, cellular compartmentalization of ferumoxtran-10 changes proton relaxivity...
  14. ncbi request reprint Cell labeling with the positive MR contrast agent Gadofluorine M
    Tobias D Henning
    Department of Radiology, University of California in San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143, USA
    Eur Radiol 17:1226-34. 2007
    ..Potential in vivo cell-tracking applications include targeting of inflammatory processes with Gadofluorine-labeled leukocytes or monitoring of stem cell therapies for the treatment of arthritis...
  15. ncbi request reprint Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research
    Gerhard H Simon
    University of California at San Francisco Medical Center, Department of Radiology, S 372, Center for Pharmaceutical and Molecular Imaging, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Acad Radiol 12:1190-7. 2005
    ..The objective is to compare three different ultrasmall superparamagnetic iron oxides (USPIOs) for magnetic resonance (MR) imaging of normal bone marrow in rodents...
  16. ncbi request reprint Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX
    Heike E Daldrup-Link
    Department of Radiology, University of California San Francisco, UCSF Medical Center, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Acad Radiol 12:502-10. 2005
    ..To compare and optimize ferumoxides labeling of human hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking with a clinical 1.5 T MR scanner...
  17. ncbi request reprint In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, 513 Parnassus Avenue, San Francisco, CA 94143 0628, USA
    Eur Radiol 15:4-13. 2005
    ....
  18. ncbi request reprint Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
    Stephan Metz
    Department of Diagnostic Radiology, Technical University Munich, Munich, Germany
    Eur Radiol 14:1851-8. 2004
    ..In vitro labeling of human monocytes for MR imaging is most effectively obtained with the approved SPIO Ferucarbotran. Potential subsequent in vivo cell tracking applications comprise, e.g. specific targeting of inflammatory processes...
  19. ncbi request reprint MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA
    Gerhard H Simon
    Department of Radiology, UCSF Medical Center, University of California San Francisco, San Francisco, California 94143, USA
    J Magn Reson Imaging 23:720-7. 2006
    ..To compare the ability of the ultrasmall superparamagnetic iron oxide (USPIO) SHU555C vs. gadopentetate dimeglumine (Gd-DTPA) to detect antigen-induced monoarthritis with MRI...
  20. ncbi request reprint MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent
    Olaf Saborowski
    Department of Radiology, UCSF Medical Center, University of California San Francisco, USA
    Contrast Media Mol Imaging 2:72-81. 2007
    ..05). Histopathology confirmed the presence of folate receptors in the inflamed joints, but not normal joints. Thus, results suggest a specific accumulation of the folate receptor-targeted Gd-chelate P866 in this arthritis model...
  21. doi request reprint Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice
    Tobias Henning
    University of California San Francisco, 185 Berry St, Suite 350, San Francisco, CA 94107, USA
    Acad Radiol 15:342-9. 2008
    ..This study was performed to assess the imaging characteristics and pharmacokinetics of 1,3-Bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol (DHOG, Fenestra LC), a hepatobiliary contrast agent for microCT...
  22. pmc MR imaging of therapy-induced changes of bone marrow
    Heike E Daldrup-Link
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143 0628, USA
    Eur Radiol 17:743-61. 2007
    ..Future developments are directed to yield comprehensive information about bone marrow structure, function and microenvironment...
  23. ncbi request reprint Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability
    Mary E Spilker
    Resource Facility for Population Kinetics, Department of Bioengineering, University of Washington, Seattle, Washington 98195 2255, USA
    J Magn Reson Imaging 22:549-58. 2005
    ..To categorize the disease severity of mammary tumors in an animal model through the application of a novel tumor permeability mixture model within a hierarchical modeling framework...
  24. ncbi request reprint Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation
    Heike E Daldrup-Link
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California, San Francisco, California 94143 0628, USA
    Microcirculation 11:387-96. 2004
    ....
  25. ncbi request reprint Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, University of California in San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
    Eur J Nucl Med Mol Imaging 31:1312-21. 2004
    ....
  26. doi request reprint Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors
    Reinhard Meier
    Department of Radiology, University of California San Francisco, CA, USA
    Nucl Med Biol 35:579-88. 2008
    ..The objective of this study was to label the human natural killer (NK) cell line NK-92 with [(18)F]fluoro-deoxy-glucose (FDG) for subsequent in vivo tracking to HER2/neu-positive tumors...